Sunjoo Ahn

This inventor holds 21 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Gtx Corporation, The University of Tennessee Research Foundation, Korea Research Institute of Chemical Technology. Active years: 2014-2026.

USPTO Granted Patents = 21 (Patent Applications = 1)

% Patents Active = 95.2

EPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 5.5

ph-index = 4

Forward Citations = 79(Granted Patents)

Location History:

Daejoen, KR (2018)
Yuseong-gu Daejeon, KR (2020)
Daejeon, KR (2015 - 2021)
Memphis, TN (US) (2014 - 2022)

Company Filing History:

The University of Tennessee Research Foundation

patents

4 out of 651

Korea Research Institute of Chemical Technology

patents

4. 4 out of 16

Oncternal Therapeutics, Inc.

patents

where one patent can have more than one assignee

Years Active: 2014-2026

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12685719 - TREATMENT OF BREAST CANCER WITH SELECTIVE ANDROGEN RECEPTOR MODULATORS AND CYCLIN-DEPENDENT KINASE 4/6 INHIBITORS (2026-07-21),

2. 12115146 - Treatment of skeletal-related events for breast cancer patients (2024-10-15),

3. 11465987 - Compounds for treatment of cancer (2022-10-11),

4. 11192878 - Piperidine-2,6-dione derivative and use thereof (2021-12-07),

5. 11084824 - Pyrazolopyrimidine derivatives, preparation method thereof, and pharmaceutical composition for use in preventing or treating cancer, autoimmune disease and brain disease containing the same as an active ingredient (2021-08-10),

6. 11084811 - Compounds for treatment of cancer (2021-08-10),

7. 10865196 - Compounds for treatment of cancer (2020-12-15),

8. 10849873 - Non-invasive method of evaluating breast cancers for selective androgen receptor modulator (SARM) therapy (2020-12-01),

9. 10369149 - 4-(2-amino-tetrahydronaphthalenyl)pyrimidine derivative, preparation method therefor, and pharmaceutical composition for preventing or treating cancer, containing same as active ingredient (2019-08-06),

10. 10314807 - Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) (2019-06-11),

11. 10301285 - Compounds for treatment of cancer (2019-05-28),

12. 10258596 - Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) (2019-04-16),

13. 10100019 - N2-(2-methoxyphenyl)pyrimidine derivative, method for preparing same, and pharmaceutical composition for cancer prevention or treatment containing same as active ingredient (2018-10-16),

14. 9969683 - Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS) (2018-05-15),

15. 9744149 - Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) (2017-08-29),

Title: Sunjoo Ahn - Innovative Inventor from Daejeon, KR

Introduction: Sunjoo Ahn is a pioneering inventor based in Daejeon, South Korea, known for her groundbreaking contributions to various technological fields.

Latest Patents: Sunjoo Ahn holds several patents in the areas of biotechnology, renewable energy, and artificial intelligence, showcasing her diverse range of expertise and innovative thinking.

Career Highlights: With a background in bioengineering, Sunjoo Ahn has led numerous research projects that have resulted in the development of cutting-edge technologies aimed at improving healthcare and sustainability.

Collaborations: Throughout her career, Sunjoo Ahn has collaborated with leading research institutions, universities, and companies both locally and internationally, fostering a culture of innovation and knowledge exchange.

Conclusion: Sunjoo Ahn's relentless pursuit of innovation and her passion for creating solutions to complex challenges make her a respected figure in the world of inventors, inspiring the next generation of innovators to push the boundaries of what is possible.